Best Life Sciences Tech Companies in Germany
The 231 best Life Sciences Tech companies in Germany in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: ResearchGate.
Germany's Life Sciences Tech sector doesn't have a unicorn yet, but 231 tracked companies and $392M in disclosed funding say this market is building real weight. Aignostics leads the pack at $55M raised, with Evotec at $25M and StratifAI at $16M rounding out a top tier that skews toward AI-driven diagnostics and clinical intelligence. So where's the momentum coming from? Median app install growth is running at roughly +43% year-on-year across health and life sciences platforms, which tells you digital adoption is accelerating faster than the funding headlines suggest. Investors like HTGF, EIC Fund, and Bayern Kapital are staying active, and regulatory compliance is increasingly a demand driver in its own right, pushing companies to build compliance logic into their core product rather than bolt it on later.
According to LifeSciencesIntelligence, the broader market context rewards companies that treat intellectual property protection and next-generation research workflows as table stakes, not features. I'd watch StratifAI and Aignostics closely here, both positioned squarely in that thesis. With no unicorns yet, the ceiling feels open, and the combination of deep-pocketed pan-European backers and a maturing regulatory environment means the companies you see ranked on this page are competing for a breakout moment that looks increasingly close.
- EVERSANA
Our analysis of 50 Life Sciences Tech companies
$9.6b in tracked funding; 89% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Tech companies in Germany
| # | Company | Disclosed funding | Last round | Stage | Employees | Founder | Web popularity | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ResearchGate Online community for scientists | $88M | 66 mo ago | Series D | 150 150 → 351 (+134%) | Horst Fickenscher CIO & Co-Founder | Top 500k | — | 1 partnership |
| 2 | Aignostics Developer of artificial intelligence software for biomedical image analysis applications 64AI top 25%Growth top 26%Funding top 27%Talent top 28% All 11 signals ▾AItop 25% Growthtop 26% Fundingtop 27% Talenttop 28% Moattop 39% Innovationtop 47% Patentstop 47% Techbottom 49% Globalbottom 37% Marketbottom 35% Newsbottom 18% AI: Classified as an AI company · Holds AI/ML patents (G06N-family CPC) Growth: Headcount 10 → 25 (+150%) across vintages · Web rank 5,000,000 → 10,000,000 YoY rank vs industry peers · Fliar Intelligence Index 64/100 | $55M | 19 mo ago | Series B | 25 | Maximilian Alber Co-Founder & CTO | Top 5M | 5 patents AI-driven detection and classification of biological structures for medical imaging diagnostics | 1 partnership · 1 award |
| 3 | Definiens Provides image analysis and data mining solutions for quantitative digital pathology in the healthcare… | $33M | 137 mo ago | Acquired | 136 | — | — | 137 patents Patents concentrated in computing, sensing & instrumentation | — |
| 4 | Molecular Health Genomic software solutions for healthcare providers | $27M | 127 mo ago | Late Stage | 121 121 → 66 (-45%) | Friedrich Bohlen Founder & CEO | Top 50M | 59 patents Computational genomics and clinical decision-support platforms for adverse event and cancer analysis | — |
| 5 | Evotec AI-driven life science company accelerating drug discovery and development 91Talent top 18%Funding top 21%Fin. health top 21%Patents top 26% All 13 signals ▾Talenttop 18% Fundingtop 21% Fin. healthtop 21% Patentstop 26% Newstop 26% Markettop 27% Partnerstop 28% Moattop 29% Techtop 33% Growthtop 35% Globaltop 35% Innovationtop 40% AItop 45% Talent: Analyst team rating 4/5 · 13 leadership moves in 12 mo Funding: Raised $25.0M across 16 rounds · 16 rounds over 28 yrs (0.6/yr) rank vs industry peers · Fliar Intelligence Index 91/100 | $25M | 5 mo ago | Public | 252 | — | Top 5M | 363 patents Small‑molecule therapeutics targeting oncology, infectious diseases, and fibrosis via tetrahydrothiazepine scaffolds | 1 launch · 1 award |
| 6 | Mindpeak Provider of AI-based pathological analysis platform 48AI top 20%Funding top 35%Patents top 42%Moat top 42% All 9 signals ▾AItop 20% Fundingtop 35% Patentstop 42% Moattop 42% Innovationtop 43% Talentbottom 49% Techbottom 41% Globalbottom 39% Marketbottom 34% AI: Classified as an AI company · Holds AI/ML patents (G06N-family CPC) Funding: Raised $18.3M across 4 rounds · 4 rounds over 7 yrs (0.6/yr) rank vs industry peers · Fliar Intelligence Index 48/100 | $18M | 20 mo ago | Series A | 28 | Felix Faber Co-Founder & CEO | Top 10M | 7 patents Patents concentrated in computing, sensing & instrumentation | — |
| 7 | StratifAI Developer of multimodal artificial intelligence models to improve cancer diagnosis and treatment 55Talent top 28%AI top 30%Funding top 32%Tech top 42% All 7 signals ▾Talenttop 28% AItop 30% Fundingtop 32% Techtop 42% Growthtop 45% Globalbottom 39% Marketbottom 29% Talent: 4 named leaders on record · 4 C-suite/founder profiles curated AI: Classified as an AI company · Product described with: artificial intelligence rank vs industry peers · Fliar Intelligence Index 55/100 | $16M | 8 mo ago | Series A | — | Firas Khader CTO & Co-founder | Top 10M | — | — |
| 8 | Molecule Platform where drug development researchers and investors collaborate to invent therapeutics | $13M | 47 mo ago | Seed | 31 | Paul Kohlhaas Co-Founder & CEO | Top 50M | — | 1 launch |
| 9 | Apheris Provider of data analytics solutions for life science industry 53AI top 20%Growth top 35%Talent top 38%Funding top 39% All 10 signals ▾AItop 20% Growthtop 35% Talenttop 38% Fundingtop 39% Partnerstop 41% Techbottom 43% Globalbottom 39% Moatbottom 38% Marketbottom 30% Newsbottom 18% AI: Classified as an AI company Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 53/100 | $12M | 17 mo ago | Series A | 19 | Robin Rohm Co-Founder & CEO & MD | Top 10M | — | — |
| 10 | PeakData Provider of a software platform to identify and analyze key opinion leaders | $12M | 45 mo ago | Series A | 55 | Michael Feldman Co-Founder | Top 50M | — | — |
| 11 | Labforward Laboratory data, devices, and researchers collaboration platform | $10M | 61 mo ago | Acquired | 45 | — | Top 10M | — | — |
| 12 | InterMed Discovery Natural Product lead-discovery | $10M | 209 mo ago | Deadpooled | — | Thomas Henkel Co-Founder & Director | — | 56 patents Small-molecule LXR agonists and HIF‑1 inhibitors for obesity, metabolic and cancer therapies | — |
| 13 | XO Life Provider of digital platform for pharmaceutical and medical device treatment support 48Patents top 19%Moat top 25%Talent top 28%Growth top 35% All 11 signals ▾Patentstop 19% Moattop 25% Talenttop 28% Growthtop 35% Fundingtop 40% Innovationtop 44% Productbottom 45% Techbottom 44% Globalbottom 44% Marketbottom 28% Newsbottom 22% Patents: 82 patents matched (strict assignee match) · 29 filings since 2022 vs 28 in 2017-21 Moat: Editorial + unicorn rating 7/10 · IP moat: 82 patents rank vs industry peers · Fliar Intelligence Index 48/100 | $10M | 21 mo ago | Series A | 25 | Philipp Naegelein Co-Founder | Top 50M | 82 patents Molecular biology automation: nucleic acid synthesis, fluorescence imaging, and spectral/auto‑focus instrumentation. | — |
| 14 | Semalytix Provider of an AI based data analytics solution for reserachers 64AI top 22%Growth top 28%Funding top 36%Talent top 41% All 8 signals ▾AItop 22% Growthtop 28% Fundingtop 36% Talenttop 41% Moattop 48% Techbottom 46% Marketbottom 44% Globalbottom 37% AI: Classified as an AI company · Product described with: ai based, ai-based, artificial intelligence Growth: Headcount 54 → 67 (+24%) across vintages · Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 64/100 | $8M | 7 mo ago | Series B | 67 67 → 44 (-34%) | Janik Jaskolski Chief Product Officer | Top 10M | — | — |
| 15 | CertHub Provider of quality management system and documentation solutions for medical device manufacturers 32Talent top 38%Funding top 40%Market bottom 37%Global bottom 36% All 4 signals ▾Talenttop 38% Fundingtop 40% Marketbottom 37% Globalbottom 36% Talent: 2 named leaders on record · 2 C-suite/founder profiles curated Funding: Raised $7.3M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 32/100 | $7M | 5 mo ago | Seed | — | Nicolas Gehring Co-Founder & CTO | — | — | — |
| 16 | Climedo Provider of digital database platform for clinical research | $6M | 52 mo ago | Seed | 62 | Sascha Ritz Co-Founder & CEO | Top 50M | — | — |
| 17 | Nostos Genomics Developer of AI platform for interpretation of genetic variants and mutations | $6M | 52 mo ago | Seed | 20 | — | Top 50M | 3 patents Computational tools for classifying and prioritizing genetic variants in genomics | — |
| 18 | Virtonomy Provider of virtual patient simulation for medical device development | $4M | 38 mo ago | Seed | 18 | Simon Sonntag Co-Founder & CEO | Top 50M | 10 patents Automated virtual patient fitting and visual analysis for medical device design and testing. | — |
| 19 | Cellbyte AI-driven analytics platform that enables pricing and market access professionals in the pharmaceutical… 40Talent top 28%AI top 35%Funding top 39%Global bottom 48% All 6 signals ▾Talenttop 28% AItop 35% Fundingtop 39% Globalbottom 48% Techbottom 43% Marketbottom 25% Talent: 3 named leaders on record · 3 C-suite/founder profiles curated AI: Product described with: ai-driven, natural language processing rank vs industry peers · Fliar Intelligence Index 40/100 | $3M | 6 mo ago | Seed | — | Felix Steinbrenner Co-Founder | Top 50M | — | — |
| 20 | UniteLabs Provider of an automation operating system for laboratory workflows 37Talent top 38%AI top 45%Funding bottom 43%Market bottom 37% All 5 signals ▾Talenttop 38% AItop 45% Fundingbottom 43% Marketbottom 37% Globalbottom 37% Talent: 2 named leaders on record · 2 C-suite/founder profiles curated AI: Product described with: ai-driven rank vs industry peers · Fliar Intelligence Index 37/100 | $3M | 14 mo ago | Seed | — | Robert Zechlin Co-Founder & Co-CEO | — | — | — |
| 21 | Biomax Informatics Knowledge Management Services for the Life Science Industry | $3M | 55 mo ago | Public | 46 | — | — | 14 patents AI-driven neuroinformatics for clinical diagnostics and pathological condition analysis | — |
| 22 | Biologs Provider of genetic information management tool | $3M | 125 mo ago | Funding Raised | 7 | — | — | — | — |
| 23 | Healthmetrix Digital solutions to aggregate and analyze data from multiple sources for research purposes | $2M | 89 mo ago | Funding Raised | — | Gabriel Sieglerschmidt Founder & CEO | — | — | — |
| 24 | Exazyme Developer of an AI protein design tool for biotech innovators | $2M | 37 mo ago | Seed | 5 | Jelena Ivanovska Co-Founder | — | — | — |
| 25 | Differential Bio Provider of bioprocess optimization through robotic lab automation and AI insights | $2M | 14 mo ago | Seed | — | Martin Patz Co-Founder & CTO | Top 10M | — | — |
| 26 | Yendou Provider of a site engagement platform for clinical trials | $1M | 27 mo ago | Seed | — | Zina Sarif Founder & CEO | Top 50M | — | 1 partnership |
| 27 | Yendou Provider of data management and CRM platform for clinical operations | $1M | 27 mo ago | Seed | 3 | Patrick Rogg Co-Founder | — | — | — |
| 28 | esqLABS Provider of workflow management tools for drug research and discovery | $1M | 61 mo ago | Funding Raised | 9 | Stephan Schaller Founder & CEO | Top 10M | — | — |
| 29 | Molecular Networks Cheminformatics software for drug discovery | $1M | 61 mo ago | Funding Raised | — | Johann Gasteiger Founder | Top 50M | — | — |
| 30 | geneXplain Provider of bioinformatics and systems biology software | $1M | 101 mo ago | Funding Raised | — | Edgar Wingender Founder & CEO | Top 5M | 4 patents Small-molecule quinoxaline inhibitors of thioredoxin reductase for therapeutic use | — |
| 31 | Arivis Biomedical big image data and compliance software | $998K | 125 mo ago | Seed | 34 34 → 25 (-26%) | — | — | 13 patents Advanced 3D medical image visualization and segmentation alignment for AR/VR platforms | — |
| 32 | Insilico Biotechnology In silico cell models for drug design and discovery. | $624K | 129 mo ago | Acquired | 29 | — | — | 27 patents Machine‑learning‑driven metabolic and bioprocess optimization for cell‑culture production | — |
| 33 | OakLabs Scientific Provider of laboratory analyses and AI algorithms for customers | $610K | 137 mo ago | Seed | 9 | Corinna Horn Co-Founder / Co-CEO / CMO | — | — | — |
| 34 | Biobyte solutions Provider of customized bioinformatics tools and consulting services | $606K | 89 mo ago | Funding Raised | — | Ivica Letunic CEO | Top 5M | — | — |
| 35 | Transinsight Enterprise Semantic Intelligence | $605K | 245 mo ago | Public | 4 | Liliana Barrio-Alvers Co-Founder | — | — | — |
| 36 | ecSeq Provider of computational tools for the analysis of genomic sequencing data | $559K | 105 mo ago | Funding Raised | — | David Langenberger CEO | Top 10M | — | — |
| 37 | BioNeex Provider of SaaS-based drug licensing and drug candidate partnership exchange platform for the biopharma… | $500K | 28 mo ago | Seed | 13 | Smbat Rafayelyan Founder & CEO | — | — | 1 launch · 1 partnership |
| 38 | Gremse-IT Provider of a software for biomedical image data reconstruction and analysis | $494K | 40 mo ago | Funding Raised | — | Felix Gremse Founder & CEO | Top 50M | — | 1 launch |
| 39 | AptaIT Provider of a software tool for data analysis of next-generation sequencing data | $367K | 137 mo ago | Deadpooled | — | Michael Blank Co-Founder & CSO | — | — | — |
| 40 | SIMFO Developer of analytics platform for cancer therapy | $366K | 79 mo ago | Funding Raised | 12 | Ulrich Pachmann CEO & MD | — | — | — |
| 41 | SCiLS Provider of mass spectrometry imaging and data analysis software for researchers | $358K | 137 mo ago | Acquired | — | Michael Schubert Managing Director | — | — | — |
| 42 | LIFE & BRAIN Provides research and development for biomedical and neuroscientific technology platform | $326K | 77 mo ago | Funding Raised | — | Markus Nothen Co-Founder & Co-CEO | Top 50M | 83 patents Scalable production platforms for human neural and microglial cell cultures and optical voltage sensing | 1 job opening |
| 43 | Ribocon Provider of software for identification of microbes based on ribosomal RNA gene sequences | $295K | 134 mo ago | Funding Raised | — | Frank Oliver Glockner Founder | — | — | — |
| 44 | Labvanced Platform that enables researchers to design, conduct, and analyze online experiments | $290K | 80 mo ago | Public | — | Caspar Goeke CEO | Top 5M | — | — |
| 45 | Avant-garde Materials Simulation Provider of AI/ML-assisted parameter generation for ab-initio-grade force fields | $284K | 40 mo ago | Funding Raised | — | Elsa Gheziel-Neumann Human Ressources and Communication Director - CEO | — | — | — |
| 46 | BioVariance Crowd-sourced platform for capture and analysis of drug dosage, adherence and adverse events | $260K | 77 mo ago | Funding Raised | 18 | Josef Scheiber Founder & MD | Top 50M | 2 patents Syringe‑compatible medicament delivery devices and associated usage systems | — |
| 47 | Globosoft Digital platform to optimize the drug development process of drug manufacturers | $171K | 96 mo ago | Deadpooled | — | Georg Tiler Managing Director | — | — | — |
| 48 | Oculyze Automated platform for yeast cell analysis and fermentation tracking | $118K | 85 mo ago | Seed | 11 | Ulrich Tillich Co-Founder & Co-CEO | Top 5M | 9 patents Portable microscope hardware for mobile imaging and on‑site sample analysis | — |
Top 12 Life Sciences Tech companies in Germany
#1
Public · Hamburg, Hamburg · founded 1993 · 252 employees$25Mraised▾
AI-driven life science company accelerating drug discovery and development. It is focused on pioneering drug discovery and preclinical development using advanced technologies, deep disease expertise, and integrated R&D platforms. It accelerates the creation of new therapies across modalities, including small molecules and biologics, to bring life-changing medicines to patients faster.
- Jan 2026Grant (prize money)—
- May 2025Grant (prize money)$2.5M
- Apr 2025Grant (prize money)$654.4K
- Jun 2023Grant (prize money)$1.7M
#2
Seed · Augsburg, Bavaria · founded 2024$7.3Mraised▾
Provider of quality management system and documentation solutions for medical device manufacturers. It provide scripts, systemd units, and docker images for centralized TLS certificate management with git as a backend.
- Jan 2026Seed$7.3M
#3
Series A · Berlin, Berlin · founded 2023$16.3Mraised▾
Developer of multimodal artificial intelligence models to improve cancer diagnosis and treatment. The company's proprietary algorithms analyze the image, assessing various patterns that indicate the recurrence risk of breast cancer to provide a comprehensive prognostic evaluation.
- Sep 2025Series A$14.7M
- Sep 2024Seed$1.7M
#4
Series B · Bielefeld, North Rhine Westphalia · founded 2015 · 67 employees$7.5Mraised▾
Semalytix is an AI-based data analytics solution. The company leverages artificial intelligence and machine learning to offers an analytics solution for marketing, business analytics, financial services, and pharmaceutical. The company has developed products like Pharos which has the ability to make decisions based on patients' health data, population data, and more.
- Oct 2025Series B$6.6M
- Feb 2021Series A$2.4M
- Aug 2020Series A$5.1M
- Jan 2019Grant (prize money)$393K
#5
Seed · Munich, Bavaria · founded 2024$3.2Mraised▾
AI-driven analytics platform that enables pricing and market access professionals in the pharmaceutical industry. It leverages natural language processing that enables users to extract insights from vast amounts of pharmaceutical data, streamlining the process of launching new drugs.
- Nov 2025Seed$2.8M
- Seed$500K
#6
Series B · Berlin, Berlin · founded 2018 · 25 employees$55Mraised▾
Developer of artificial intelligence software for biomedical image analysis applications. This technology processes pathology samples to identify drug targets and biomarkers. The software utilizes foundation models to generate embeddings for downstream analysis of tumor microenvironments. These tools support research in drug development and clinical diagnostics by predicting expression patterns and classifying cell types within tissue images.
- Oct 2024Series B$34M
- Sep 2022Series A$14M
- Aug 2020Seed$5.9M
#7
Series A · Berlin, Berlin · founded 2019 · 19 employees$12.2Mraised▾
Provider of data analytics solutions for life science industry. The platform enables organizations to collaborate on distributed data in real time. It offers a federated computational governance solution to support data-driven analysis. The platform allows users to build federated data networks to enable hospitals, fellow researchers and other pharmaceutical innovators to build predictive models.
- Jan 2025Series A$20.8M
- Nov 2022Seed$8.7M
- Aug 2020Seed$3M
- Grant (prize money)—
#8
Series A · Hamburg, Hamburg · founded 2017 · 28 employees$18.3Mraised▾
MindPeak provides a platform for pathological analysis. The platform helps in automating microscopical and pathological analysis. The platform uses artificial intelligence and deep learning for their analysis and the company is focused on the diagnosis of cancer.
- Sep 2024Series A$15.3M
- Aug 2020Grant (prize money)$1.6M
- Jun 2020Grant (prize money)$2.2M
- Sep 2019Seed$3M
#9
Seed · Munich, Bavaria · founded 2017$3Mraised▾
Provider of an automation operating system for laboratory workflows. It offers a vendor-agnostic integration layer unifying hardware, data, and APIs across the lab. A flexible logic layer allows automation of workflows, from single experiments to full-facility control. The system includes AI-ready infrastructure for real-time control, bridging digital insights and physical execution. It provides low-level control of liquid handlers via a Python SDK, enabling scalable automation. Fleet management capabilities utilize modern DevOps tools for efficient workflow deployment and management. The platform facilitates AI-driven lab operations through self-describing interfaces and workflow generation libraries. A secure, accessible data storage solution centralizes structured and unstructured data. Finally, it offers bidirectional connectivity, an open cloud API, a production-ready workflow engine, and a modular automation toolbox enabling lab-as-code practices.
- Apr 2025Seed$3M
- Nov 2017Seed$10.2K
#10
Series A · Munich, Bavaria · founded 2016 · 25 employees$10.1Mraised▾
Provider of digital platform for pharmaceutical and medical device treatment support. The platform connects pharmaceutical companies and experts with patients, providing digital support. It offers health-related content, product and therapy information, and real-world patient data. The platform also digitizes pharmacovigilance, collecting and tracking patient reports on product side effects.
- Aug 2024Series A$7.8M
- Feb 2022Seed$2.3M
- Aug 2018Grant (prize money)$58.3K
#11
Seed · Feldkirchen, Bavaria · founded 2024$2.2Mraised▾
Provider of bioprocess optimization through robotic lab automation and AI insights. It offers a virtual scale-up platform for bioprocess development and optimization. The company provides tools for data collection, digital modeling, and bioprocess parameter optimization. It allows users to simulate fermentation outcomes and implement process parameters for scale-up.
- Mar 2025Seed$2.2M
#12
Series D · Berlin, Berlin · founded 2008 · 150 employees$87.6Mraised▾
ResearchGate is an online community for scientists and researchers to share papers, ask and answer questions, and find collaborators. It has a blogging feature for users to write short reviews on peer-reviewed articles. It also has private chat rooms where scientists can share data, edit shared documents, and discuss confidential topics. The application is available for iOS devices.
- Dec 2020Grant (prize money)$18.5K
- Feb 2017Series D$52.6M
- May 2013Series C$35M
- Feb 2012Series B—
Funding & investor landscape
Notable founders
How research on Biotechnology is moving in Germany
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 1,297 Germany-affiliated papers.
- Heidelberg University85
- German Cancer Research Center49
- Ludwig-Maximilians-Universität München48
- Technical University of Munich43
- Karlsruhe Institute of Technology33
- Gene3→29
- Mutant3→19
- Transcription (linguistics)3→16
- Messenger RNA1→14
- Immune system1→12
- Gene3→20
- Agriculture2→12
- Extracellular1→11
- Immune system1→11
- Transcriptome1→9
- Antibiotic resistance2→9
- Gene1→7
- Agriculture4→9
- Antimicrobial1→4
- Microbiome1→4
Where biotechnology is researched across Germany
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing biotechnology patents in Germany
Germany biotechnology patent filing is cooling — 53,233 filings from 8,000 assignees (2016–2025), led by Immatics Biotechnologies, BASF Plant Science, BASF SE; annual filings 4819→4267.
- Immatics Biotechnologies4875
- BASF Plant Science3993
- BASF SE3545
- Boehringer Ingelheim INT3440
- Merck Patent3137
- MAX Planck Gesellschaft1805
- Evonik Degussa1683
- Amgen RES Munich1665
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.